1. Home
  2. DHC vs OGN Comparison

DHC vs OGN Comparison

Compare DHC & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Diversified Healthcare Trust of Beneficial Interest

DHC

Diversified Healthcare Trust of Beneficial Interest

HOLD

Current Price

$7.37

Market Cap

1.7B

Sector

Real Estate

ML Signal

HOLD

Logo Organon & Co.

OGN

Organon & Co.

HOLD

Current Price

$9.69

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DHC
OGN
Founded
1998
1923
Country
United States
United States
Employees
585
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.5B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
DHC
OGN
Price
$7.37
$9.69
Analyst Decision
Buy
Hold
Analyst Count
2
4
Target Price
$7.25
$11.75
AVG Volume (30 Days)
1.4M
6.4M
Earning Date
05-04-2026
05-07-2026
Dividend Yield
0.56%
0.86%
EPS Growth
N/A
N/A
EPS
N/A
0.72
Revenue
N/A
$6,216,000,000.00
Revenue This Year
$3.13
$0.45
Revenue Next Year
$7.00
$1.67
P/E Ratio
N/A
$12.94
Revenue Growth
N/A
N/A
52 Week Low
$2.15
$5.69
52 Week High
$7.66
$13.25

Technical Indicators

Market Signals
Indicator
DHC
OGN
Relative Strength Index (RSI) 59.32 76.35
Support Level $6.46 $8.63
Resistance Level $7.64 $10.10
Average True Range (ATR) 0.30 0.58
MACD 0.03 0.42
Stochastic Oscillator 85.64 96.66

Price Performance

Historical Comparison
DHC
OGN

About DHC Diversified Healthcare Trust of Beneficial Interest

Diversified Healthcare Trust is a real estate investment trust that focuses on healthcare-related properties, including life science estates, medical offices, and senior living communities. It acquires and owns properties and is engaged in the development and implementation of medical services and technologies. The company has two reportable segments: SHOP (Senior Housing Operating Portfolio) and Medical Office and Life Science Portfolio. The SHOP segment includes managed senior living communities providing residential living and care services. The Medical Office and Life Science Portfolio segment consists of properties leased to medical providers and biotechnology laboratories. It generates the majority of its revenue from the SHOP segment.

About OGN Organon & Co.

Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.

Share on Social Networks: